RunaPharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RunaPharma
Largest movements
- Cash +€35
up €35 (+22.6%), from €154 to €189
mainly Other debts (+€1,328)
- Other debts +€1,328
up €1,328 (+7.8%), from €16,922 to €18,249
- Profit (loss) carried forward -€1,293
down €1,293 (-3.5%), from -€36,767 to -€38,060
- Gross operating margin +€1,197
up €1,197 (+64.5%), from -€1,856 to -€659
- Other operating charges +€97
up €97 (+19.7%), from €493 to €590
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €154 | €189 | +€35 | +22.6% |
| Current assets | 29/58 | €154 | €189 | +€35 | +22.6% |
| Cash at bank and in hand | 54/58 | €154 | €189 | +€35 | +22.6% |
| Total equity and liabilities | 10/49 | €154 | €189 | +€35 | +22.6% |
| Equity | 10/15 | -€16,767 | -€18,060 | -€1,293 | -7.7% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€36,767 | -€38,060 | -€1,293 | -3.5% |
| Amounts payable | 17/49 | €16,922 | €18,249 | +€1,328 | +7.8% |
| Amounts payable within one year | 42/48 | €16,922 | €18,249 | +€1,328 | +7.8% |
| Other amounts payable | 47/48 | €16,922 | €18,249 | +€1,328 | +7.8% |
| Other operating charges | 640/8 | €493 | €590 | +€97 | +19.7% |
| Gross operating margin | 9900 | -€1,856 | -€659 | +€1,197 | +64.5% |
| Operating profit (loss) | 9901 | -€2,349 | -€1,250 | +€1,100 | +46.8% |
| Financial charges | 65/66B | €39 | €44 | +€5 | +11.5% |
| Recurring financial charges | 65 | €39 | €44 | +€5 | +11.5% |
| Profit (loss) for the period before taxes | 9903 | -€2,388 | -€1,293 | +€1,095 | +45.9% |
| Profit (loss) for the period | 9904 | -€2,388 | -€1,293 | +€1,095 | +45.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,388 | -€1,293 | +€1,095 | +45.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.